Fluconazole: Difference between revisions
From IDWiki
(→) |
No edit summary |
||
Line 1: | Line 1: | ||
==Background== |
|||
== Classification == |
|||
* |
*Antifungal in the triazole family with excellent bioavadilability but limited efficacy outside of ''Candida'' |
||
⚫ | |||
== Indications == |
|||
⚫ | |||
* Fungal infections |
|||
⚫ | |||
* Fungistatic |
|||
* Susceptibility breakpoints for [[Candida albicans]] are: |
|||
** Susceptible MIC ≤2 |
|||
** Susceptible dose-dependent MIC 4 |
|||
** Resistant MIC ≥8 |
|||
== |
==Monitoring== |
||
* |
*ECG for QT prolongation |
||
* |
*Liver enzymes for hepatitis |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
**EKG ([[Adverse drug reaction::QTc prolongation]]) |
|||
⚫ | |||
* |
*Beware [[Adverse drug reaction::drug-drug interactions]], especially with new DOACs |
||
* Beware [[Adverse drug reaction::drug-drug interactions]], especially with new DOACs |
|||
[[Category:Antifungals]] |
[[Category:Antifungals]] |
Revision as of 16:16, 21 August 2020
Background
- Antifungal in the triazole family with excellent bioavadilability but limited efficacy outside of Candida
Pharmacokinetics and Pharmacodynamics
- Good oral bioavailability
- Good CNS penetration
- Fungistatic
- Susceptibility breakpoints for Candida albicans are:
- Susceptible MIC ≤2
- Susceptible dose-dependent MIC 4
- Resistant MIC ≥8
Monitoring
- ECG for QT prolongation
- Liver enzymes for hepatitis
Adverse Drug Reactions
- Best side effect profiles of the antifungals
- Before starting, check:
- Liver enzymes as baseline (hepatitis)
- Creatinine (requires renal dosing)
- EKG (QTc prolongation)
- Beware drug-drug interactions, especially with new DOACs